Ledger.Open graph →
SEC Form D · filed May 19, 2020

Nutcracker Therapeutics, Inc

Offering
$60.0M
Sold
$14.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
EMERYVILLE, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

Igor Khandros · Emeryville, CAExec · DirectorKenrick Brice Toussaint · BAYSIDE, NYExec · DirectorRobert Nelsen · Seattle, WADirectorRobert T. Dean · Milwaukee, WIExec · DirectorRobert Nelsen · Hampton, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗